Ironwood Pharmaceuticals Inc (IRWD): Net Income
$24.02M
Year ended 2025-12-31
$129.87M
Trailing 12 months to 2026-06-30
-48.4%
3-year compound annual growth
-25.7%
5-year compound annual growth
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.02M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $880.0K | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$1.03B | n/m | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $175.06M | -66.9% | 2025-03-31, From 2022-01-01 |
| 2021-12-31 | $528.45M | +397.7% | 2024-02-16, From 2021-01-01 |
| 2020-12-31 | $106.18M | +393.7% | 2023-02-16, From 2020-01-01 |
| 2019-12-31 | $21.50M | n/m | 2022-02-18, From 2019-01-01 |
| 2018-12-31 | -$282.37M | n/m | 2021-02-17, From 2018-01-01 |
| 2017-12-31 | -$116.94M | n/m | 2020-02-13, From 2017-01-01 |
| 2016-12-31 | -$81.71M | n/m | 2019-02-25, From 2016-01-01 |
| 2015-12-31 | -$142.67M | n/a | 2018-02-22, From 2015-01-01 |
| No annual figure between 2012-12-31 and 2015-12-31. | |||
| 2012-12-31 | -$72.62M | n/m | 2013-02-21, From 2012-01-01 |
| 2011-12-31 | -$64.85M | n/m | 2013-02-21, From 2011-01-01 |
| 2010-12-31 | -$51.86M | n/m | 2013-02-21, From 2010-01-01 |
| 2009-12-31 | -$73.31M | n/a | 2012-02-29, From 2009-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $24.02M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$51.64M | n/m |
| Xeris Biopharma Holdings, Inc. (XERS) | 2025-12-31 | $554.0K | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $163.06M | n/m |
| Harrow, Inc. (HROW) | 2025-12-31 | -$5.14M | n/m |
| Vireo Growth Inc. (VREOF) | 2025-12-31 | -$68.11M | n/m |
| Ligand Pharmaceuticals Inc (LGND) | 2025-12-31 | $124.45M | n/m |
| Arvinas, Inc. (ARVN) | 2025-12-31 | -$80.80M | n/m |
| Schrodinger, Inc. (SDGR) | 2025-12-31 | -$103.27M | n/m |
Compare IRWD, EOLS, XERS, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗